However, the small-scale study had not been powered to compare clinical endpoints, and thus, difference in the incidence of clinically driven target lesion revascularization (TLR) between groups did not reach statistical significance (DCB 15.4% vs.
← all excerpts
Paclitaxel-Coated Balloon Angioplasty in the Real World: Jack-of-all-Trades?
1
—
—